ArticleCureus2025
Advanced Diffuse Systemic Sclerosis With Progressive Esophageal Dysfunction: Clinical Challenges in a Public Hospital.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diffuse systemic sclerosis (SS) is a rare autoimmune connective tissue disorder characterized by widespread fibrosis, vasculopathy, and autoantibody production. Gastrointestinal involvement, particularly esophageal dysfunction, is among the most frequent and morbid manifestations. Diagnosing and managing these complications can be especially challenging in advanced disease stages and in resource-limited settings, where specialized investigations and treatments may be inaccessible. We report a 34-year-old woman with diffuse SS who developed rapidly progressive oral intolerance, severe malnutrition, and superinfected cutaneous ulcerations. Barium esophagography demonstrated markedly delayed esophageal clearance, consistent with advanced esophageal dysmotility. Esophageal manometry and endoscopy could not be performed due to patient intolerance and restricted oral opening. Despite aggressive management including cyclophosphamide, targeted antibiotic therapy, and supportive care, the patient's condition deteriorated, culminating in multi-organ failure secondary to septic shock. This case illustrates the aggressive and life-threatening nature of gastrointestinal involvement in diffuse SS. It underscores the diagnostic and therapeutic challenges faced in resource-constrained environments and highlights the critical importance of early recognition, vigilant supportive management, and adaptation of evidence-based recommendations to local healthcare realities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.